Skip to content

D&A at other companies

Biogen logo
BiogenBIIB
$204.4M+11.6%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$113K-18.7%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$271K+18.3%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$20.92M-8.6%
uniQure logo
uniQureQURE
$2.96M-34.7%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$2.85M+22.4%

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's D&A?
Alpha Cognition (ACOG) reported D&A of $29.77K in Q1 2026.
How has Alpha Cognition's D&A changed year-over-year?
Alpha Cognition's D&A increased by 308.8% year-over-year, from $7.28K to $29.77K.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.